Researchers have been excited about this new drug, a novel dual agonist showing significant outcomes in initial trials for size management. It works by modulating several systems: GLP-1 and GIP, that , when engaged , support control cravings and enhance calorie burn. Preliminary findings indicate noteworthy weight loss and possible benefits for … Read More